Cargando…

Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis

The Fuzheng Huayu (FZHY) formula is being used in antiliver fibrosis treatment in China. For systemic evaluation of the curative effects of FZHY on liver fibrosis and cirrhosis progress, a total of 1392 subjects (714 cases and 678 controls) were found to be eligible for meta-analysis in this study....

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Shu, Chen, Qi-Long, Su, Shi-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499386/ https://www.ncbi.nlm.nih.gov/pubmed/26221168 http://dx.doi.org/10.1155/2015/125659

Ejemplares similares

Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis
por: Chen, Qi-Long, et al.
Publicado: (2015)

Effect of Fuzheng Huayu formula and its actions against liver fibrosis
por: Liu, Chenghai, et al.
Publicado: (2009)

Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism
por: Li, Qing-Ya, et al.
Publicado: (2013)

Antiliver Fibrosis Formula of Fuzheng Huayu Alleviates Inflammatory Response
por: Chang, Qing-Qi, et al.
Publicado: (2022)

Traditional Chinese Medicine Fuzheng Huayu Prevents Development of Liver Fibrosis in Mice
por: Jiang, Chunyan, et al.
Publicado: (2020)

Proteomic Analysis of the Effect of Fuzheng Huayu Recipe on Fibrotic Liver in Rats
por: Xie, Hongdong, et al.
Publicado: (2013)

A Randomized Controlled Study of Fuzheng Huayu Capsule for Prevention of Esophageal Variceal Bleeding in Patients with Liver Cirrhosis
por: Gu, Jie, et al.
Publicado: (2013)

Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice
por: Jia, Yan-Hong, et al.
Publicado: (2012)

Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats
por: Yang, Tao, et al.
Publicado: (2019)

Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis
por: Shi, Ke, et al.
Publicado: (2020)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis
por: Gui, Hong-Lian, et al.
Publicado: (2020)

Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis
por: Tao, Yan-yan, et al.
Publicado: (2014)

Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis
por: Chen, Qilong, et al.
Publicado: (2016)

Effect of Fuzheng Huayu capsule combined with Pegasys on genotype 1 hepatitis C fibrosis and cell apoptosis
por: ZHANG, BO, et al.
Publicado: (2014)

Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet
por: Dai, Yun-Kai, et al.
Publicado: (2023)

Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis
por: Wu, Rong, et al.
Publicado: (2019)

Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I–induced kidney fibrosis through network pharmacology
por: Wang, Fan, et al.
Publicado: (2022)

Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis: A Multicenter Double-Blind Randomized Controlled Trail
por: Song, Ya-Nan, et al.
Publicado: (2013)

Cyp4a12-mediated retinol metabolism in stellate cells is the antihepatic fibrosis mechanism of the Chinese medicine Fuzheng Huayu recipe
por: Ping, Da-bing, et al.
Publicado: (2023)

The components data of fuzheng huayu extracts, cordyceps sinensis mycelia polysaccharide, gypenosides and amygdalin
por: Liu, Wei, et al.
Publicado: (2019)

Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells
por: Pan, Qin, et al.
Publicado: (2015)

Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2023)

In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa
por: Xu, Hongri, et al.
Publicado: (2020)

Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice
por: Wang, Rong-Qi, et al.
Publicado: (2015)

Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial
por: Hassanein, Tarek, et al.
Publicado: (2022)

Fuzheng Huayu Recipe Prevented and Treated CCl4-Induced Mice Liver Fibrosis through Regulating Polarization and Chemotaxis of Intrahepatic Macrophages via CCL2 and CX3CL1
por: Zhang, Man, et al.
Publicado: (2020)

The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability – A Network Pharmacology and Transcriptomics Approach
por: Xing, Xinrui, et al.
Publicado: (2018)

Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes
por: Xing, Lu, et al.
Publicado: (2022)

Simultaneous determination of eight analytes of Fuzheng Huayu recipe in beagle dog plasma by UHPLC–Q/exactive Orbitrap HRMS and its application to toxicokinetics
por: Wang, Yu‐Lin, et al.
Publicado: (2022)

Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
por: Tang, Xiao-Long, et al.
Publicado: (2022)

Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial
por: Chen, Yangyi, et al.
Publicado: (2020)

Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescence
por: Zuo, Biao, et al.
Publicado: (2022)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
por: Mu, Li-ya, et al.
Publicado: (2021)

Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis
por: Qi, Xiaolong, et al.
Publicado: (2018)

Subchronic toxicity of herbal compound “Jiedu Huayu” granules in rats
por: Wang, Minggang, et al.
Publicado: (2017)

Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury in vivo
por: Cao, Fei, et al.
Publicado: (2019)

Shenqi Fuzheng Injection in the Treatment of Breast Cancer: A Meta-analysis of Randomized Controlled Trials
por: Liu, Shuyu, et al.
Publicado: (2018)

Genomics and proteomics in liver fibrosis and cirrhosis
por: Hannivoort, Rebekka A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_phkrtp5m1ju461jjce7hh7hba6